12.38
2.60%
0.275
Third Harmonic Bio Inc stock is traded at $12.38, with a volume of 35,096.
It is up +2.60% in the last 24 hours and down -0.80% over the past month.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
See More
Previous Close:
$12.11
Open:
$11.99
24h Volume:
35,096
Relative Volume:
0.20
Market Cap:
$509.61M
Revenue:
-
Net Income/Loss:
$-32.74M
P/E Ratio:
-7.8763
EPS:
-1.5718
Net Cash Flow:
$-24.89M
1W Performance:
-14.81%
1M Performance:
-0.80%
6M Performance:
+6.15%
1Y Performance:
+90.78%
Third Harmonic Bio Inc Stock (THRD) Company Profile
Name
Third Harmonic Bio Inc
Sector
Industry
Phone
(209) 727-2457
Address
1700 MONTGOMERY STREET, SAN FRANCISCO
Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-16-22 | Downgrade | Jefferies | Buy → Hold |
Dec-15-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Oct-10-22 | Initiated | Cowen | Outperform |
Oct-10-22 | Initiated | Jefferies | Buy |
Oct-10-22 | Initiated | Morgan Stanley | Overweight |
Third Harmonic Bio Inc Stock (THRD) Latest News
(THRD) Technical Data - Stock Traders Daily
Third harmonic bio sees $14.3 million in stock sales by BVF Partners - Investing.com India
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Third Harmonic Bio's chief medical officer sells $40,095 in stock - Investing.com
A new biotech, built around protein design, springs from David Baker’s lab - BioPharma Dive
Where are the Opportunities in (THRD) - Stock Traders Daily
(THRD) Trading Signals - Stock Traders Daily
Upstream prices $255M IPO in bid to challenge Amgen, AstraZeneca asthma drug - BioPharma Dive
Startup led by John Maraganore raises $135M to build ‘future of RNAi’ - BioPharma Dive
Third Harmonic Bio: Nothing Stands Out (NASDAQ:THRD) - Seeking Alpha
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney - BioPharma Dive
How To Trade (THRD) - Stock Traders Daily
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise By Investing.com - Investing.com South Africa
Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com
WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India
Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa
Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia
Third harmonic bio executive sells over $140k in stock - Investing.com
Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World
Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat
How the (HRMY) price action is used to our Advantage - Stock Traders Daily
Hyliion Holdings Corporation [HYLN] Records 50-Day SMA of $2.01 - Knox Daily
23andMe faces Nasdaq delisting - MSN
Independent directors resign from 23andMe board after opposing move to privatize - Washington Times
23andMe Stock Falls as All Board Members Resign - Barron's
Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins
Third Harmonic Bio Inc (THRD) Stock: A Comprehensive 52-Week Review - The InvestChronicle
ME STOCK ALERT: 23andMe Holding Co. Shareholders are - GlobeNewswire
23andme board resigns : Turmoil at 23andMe: Board Resigns Amid Controversial Plans to Go Private - CGNEWS24
23andme board resigns : 23andMe Board Resigns En Masse: A Fatal Blow to the DNA Testing Giant? - CGNEWS24
Rhumbline Advisers Boosts Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Hex And PulseChain Founder Richard Heart In Hot Water With Finnish Authorities - Cryptonews
23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki - The Wall Street Journal
Crypto Influencer Richard Heart Investigated for Tax Evasion - Crypto Times
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private - New York Post
Check Out Hyliion Holdings Corporation (HYLN)’s Trade Data Rather Than the Analysts’ Views - SETE News
A Look at Harmonic, Inc. (HLIT) Shares in the Recent Past Indicates Growth - SETE News
Finnish Police Seeking Hex Founder Richard Heart for Suspected Gross Tax Evasion, Assault - Decrypt
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time - Yahoo Finance
23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan - MarketWatch
23andMe Shares Fall After Independent Directors Resign Amid Spat Over Buyout Bid - MarketWatch
23andMe down after independent directors quit board - XM
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - BNN Bloomberg
Raymond James analysts upgrades a Strong buy rating for Harmonic, Inc. (HLIT) - Knox Daily
Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain drugs - BioPharma Dive
Hyliion Holdings Corporation (HYLN) did well last session? - US Post News
HashiCorp Inc (HCP) Becoming More Attractive for Investors - Knox Daily
Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business - Yahoo Finance
Commonwealth Equity Services LLC Trims Stake in Haleon plc (NYSE:HLN) - Defense World
Third Harmonic Bio Inc Stock (THRD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Third Harmonic Bio Inc Stock (THRD) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Option Exercise |
4.20 |
2,673 |
11,227 |
2,673 |
Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Sale |
15.00 |
2,673 |
40,095 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):